NR4A3 and cancer: Although some reports suggested that epigenetic modification is involved in the silencing of NR4A3 in some cancer models (1, 44), solid evidence from a recent study demonstrated that the abrogation of NR4A3 expression in myeloid malignization was mediated by the blockade of transcriptional processing rather than epigenetic silencing (30).